Sttr phase i
Ended Purchase Order Awarded Last action
- Contract number
- W911QY18P0299
- Awardee
-
Mapp Biopharmaceutical, Inc. UEI M9V9QTHR1H28
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Obligated
- $149,999
Award facts
- Contract value 100% obligated
- $149,998.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 10 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
- Research
- STTR Phase I
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $149,999 |
About this award
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Mapp Biopharmaceutical, Inc., a San Diego-based biotechnology company. The firm-fixed-price purchase order, with a potential value of $149,998.71, is for research and development efforts related to STTR Phase I work. Mapp Biopharmaceutical has extensive experience providing therapeutic interventions and medical countermeasures against infectious diseases and biothreats to U.S. government agencies, including the Department of Health and Human Services (HHS) and the U.S. Army, through prime federal contracts and subaward partnerships. This SBIR Phase I award supports Mapp Biopharmaceutical's continued research and development of antibody-based prophylactics and therapeutics against emerging viral pathogens of epidemic potential.
Quick answers
Who was awarded contract W911QY18P0299?
W911QY18P0299 was awarded to Mapp Biopharmaceutical, Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on September 21, 2018.
How much is contract W911QY18P0299 worth?
The government has obligated $149,999 on W911QY18P0299.
Which agency awarded contract W911QY18P0299?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY18P0299, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W911QY18P0299 competed?
The extent of competition for W911QY18P0299 was full and open competition after exclusion of sources. The government received 10 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award